Publication | Closed Access

Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice

InflammationCytokineLupus-prone Mrl/lpr MiceAutoimmune DiseaseLupusMedicineImmunologyAutoimmunitySpleen CellsImmunopathologyToll-like Receptor 4Cell BiologyCell Signaling